| Literature DB >> 30683676 |
Sumit Parikh1, Amel Karaa2, Amy Goldstein3,4, Enrico Silvio Bertini5, Patrick F Chinnery6, John Christodoulou7,8, Bruce H Cohen9,10, Ryan L Davis11,12, Marni J Falk3,4, Carl Fratter13,14, Rita Horvath15,16, Mary Kay Koenig17, Michaelangelo Mancuso18, Shana McCormack3,4, Elizabeth M McCormick3, Robert McFarland19, Victoria Nesbitt19,20, Manuel Schiff21, Hannah Steele15,22, Silvia Stockler23, Carolyn Sue11,12,24, Mark Tarnopolsky25, David R Thorburn26,27,28, Jerry Vockley29, Shamima Rahman30,31.
Abstract
Primary genetic mitochondrial diseases are often difficult to diagnose, and the term 'possible' mitochondrial disease is used frequently by clinicians when such a diagnosis is suspected. There are now many known phenocopies of mitochondrial disease. Advances in genomic testing have shown that some patients with a clinical phenotype and biochemical abnormalities suggesting mitochondrial disease may have other genetic disorders. In instances when a genetic diagnosis cannot be confirmed, a diagnosis of 'possible' mitochondrial disease may result in harm to patients and their families, creating anxiety, delaying appropriate diagnosis and leading to inappropriate management or care. A categorisation of 'diagnosis uncertain', together with a specific description of the metabolic or genetic abnormalities identified, is preferred when a mitochondrial disease cannot be genetically confirmed. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: clinical genetics; diagnosis; evidence based practice; metabolic disorders
Mesh:
Substances:
Year: 2019 PMID: 30683676 DOI: 10.1136/jmedgenet-2018-105800
Source DB: PubMed Journal: J Med Genet ISSN: 0022-2593 Impact factor: 6.318